M. Labopin

A. Ganser, N. Kröger, M. Labopin, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party.

M. Labopin, A. Nagler, M. Mohty, 2020, Clinical lymphoma, myeloma & leukemia.

Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation

J. Esteve, N. Kröger, M. Labopin, 2020, American journal of hematology.

Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia

M. Labopin, A. Nagler, M. Mohty, 2020, Haematologica.

Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMT

M. Labopin, P. Chevallier, D. Blaise, 2020, Bone Marrow Transplantation.

Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: an analysis from the European Society for Blood and Marrow Transplantation

S. Fröhling, P. Pedrazzoli, A. Santoro, 2020, ESMO Open.

Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT

A. Ganser, J. Johansson, R. Fanin, 2020, Bone Marrow Transplantation.

Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT

M. Labopin, H. Sengeløv, D. Blaise, 2019, Bone Marrow Transplantation.

Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

N. Kröger, M. Labopin, I. Yakoub-Agha, 2019, Journal of Hematology & Oncology.

OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OVER 69 YEARS OF AGE WITH ACUTE MYELOID LEUKEMIA: ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT.

A. Ganser, N. Kröger, M. Labopin, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT

C. Craddock, M. Labopin, I. Yakoub-Agha, 2019, Leukemia.

Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T‐cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

P. Chiusolo, M. Labopin, D. Blaise, 2018, British journal of haematology.

Single-Dose Daily Fractionation Is Not Inferior to Twice-a-Day Fractionated Total-Body Irradiation Before Allogeneic Stem Cell Transplantation for Acute Leukemia: A Useful Practice Simplification Resulting From the SARASIN Study.

M. Labopin, I. Yakoub-Agha, A. Nagler, 2018, International journal of radiation oncology, biology, physics.

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

M. Labopin, D. Blaise, A. Nagler, 2018, Journal of Hematology & Oncology.

M. Labopin, I. Yakoub-Agha, A. Nagler, 2017, American journal of hematology.

Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients

M. Labopin, J. Finke, M. Mohty, 2012, Journal of internal medicine.

Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission.

M. Labopin, D. Blaise, G. Meloni, 2010, Blood.

Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remission.

M. Labopin, D. Blaise, R. Willemze, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia.

M. Labopin, J. Finke, M. Mohty, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Grou

M. Labopin, A. Nagler, H. Greinix, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

families with myeloproliferative disorders Genetic and clinical implications of the Val617Phe JAK2 mutation in 72

W. Vainchenker, M. Labopin, F. Delhommeau, 2013 .

Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications.

M. Labopin, C. Bellanné-Chantelot, C. Saint-Martin, 2012, Blood cells, molecules & diseases.

Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders.

G. Thomas, C. de Toma, W. Vainchenker, 2006, Blood.

Clofarabine versus fludarabine‐based reduced‐intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS

J. Bourhis, M. Labopin, P. Chevallier, 2016, Cancer medicine.

Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry

M. Labopin, J. Ouyang, B. Gruhn, 2013, Lupus.

European Group for Blood and Marrow Transplantation registry Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus : data from the

M. Labopin, J. Ouyang, B. Gruhn, 2012 .

Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission.

G. Dini, M. Labopin, G. Meloni, 2003, Blood.

Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial.

J. Satsangi, C. Hawkey, G. Rogler, 2017, The lancet. Gastroenterology & hepatology.

Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysis

H. Einsele, M. Labopin, A. Nagler, 2022, Bone Marrow Transplantation.

Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia.

M. Labopin, M. Mohty, O. Legrand, 2014, Leukemia research.

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

J. Esteve, A. Ganser, C. Craddock, 2020, Bone Marrow Transplantation.

Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

M. Labopin, D. Blaise, J. Reiffers, 1997, Blood.

Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia

A. Vekhoff, M. Labopin, M. Mohty, 2017, Bone Marrow Transplantation.

Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

M. Labopin, I. Yakoub-Agha, M. Mohty, 2014, Bone Marrow Transplantation.

High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.

C. Flamant, G. Leverger, M. Labopin, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT

M. Labopin, I. Yakoub-Agha, M. Aljurf, 2012, Leukemia.

Who Is the Best Hematopoietic Stem-Cell Donor for a Male Patient With Acute Leukemia?

A. Ganser, C. Craddock, M. Labopin, 2014, Transplantation.

Impact of FLT3 ITD/NPM1 mutation status in adult patients with acute myelocytic leukemia autografted in first remission

J. Esteve, M. Labopin, G. Meloni, 2013, Haematologica.

Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells

M. Labopin, Lingyun Sun, D. Farge-Bancel, 2019, Stem cells international.

A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia

M. Labopin, O. Ringdén, R. Zittoun, 1996, British journal of haematology.

Transplantation of peripheral blood progenitor cells from HLA‐identical sibling donors

N. Schmitz, J. Garcia-conde, M. Labopin, 1996, British journal of haematology.

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

J. D. de Vries-Bouwstra, B. Sharrack, M. Labopin, 2021, Bone Marrow Transplantation.

Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party

L. Kanz, M. Labopin, J. Snowden, 2020, Haematologica.

Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?

M. Labopin, J. Finke, J. Snowden, 2016, Bone Marrow Transplantation.

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases

M. Labopin, A. Gratwohl, J. Ouyang, 2010, Haematologica.

Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation

G. Lucchini, B. Sharrack, C. Hawkey, 2022, British journal of haematology.

Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

A. Ganser, N. Kröger, M. Labopin, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study.

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2017, Blood.

Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients

A. Vekhoff, M. Labopin, M. Mohty, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation

P. Oefner, D. Mougiakakos, M. Labopin, 2015, Bone Marrow Transplantation.

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and

M. Labopin, I. Yakoub-Agha, H. Sengeløv, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of outcomes after unrelated double-unit cord blood and haploidentical peripheral blood stem cell transplantation in adults with acute myeloid leukemia, a study on behalf of Eurocord and ALWP-EBMT.

F. Baron, M. Labopin, P. Chevallier, 2022, Transplantation and cellular therapy.

Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors.

A. Vekhoff, M. Labopin, M. Mohty, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome

M. Labopin, A. Gratwohl, D. Niederwieser, 1998, Bone Marrow Transplantation.

Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS

M. Labopin, G. Meloni, A. Gratwohl, 1997 .

Relationship between IgG titers and opsonocytophagocytic activity of anti-pneumococcal antibodies after immunization with the 7-valent conjugate vaccine in allogeneic stem cell transplant

H. Einsele, M. Labopin, K. Jansen, 2010, Bone Marrow Transplantation.

Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults.

M. Labopin, P. Chevallier, M. Mohty, 2014, Experimental hematology.

Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow Transplantation.

M. Labopin, G. Meloni, A. Gratwohl, 1997, Blood.

Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation.

H. Einsele, M. Labopin, D. Niederwieser, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Is there a graft‐versus‐leukaemia effect in the absence of graft‐versus‐host disease in patients undergoing bone marrow transplantation for acute leukaemia?

N. Schmitz, F. Mandelli, M. Labopin, 2000, British journal of haematology.

Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures

J. Petit, M. Labopin, S. Lesage, 1996, Journal of clinical microbiology.

A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplant

M. Labopin, L. Fouillard, S. Lesage, 2004, Leukemia.

Comparison of CD34+ bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniques

M. Labopin, N. Gorin, L. Douay, 1998, Bone Marrow Transplantation.

Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

M. Labopin, J. Reiffers, O. Ringdén, 1996, Bone marrow transplantation.

Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study

R. Emsley, M. Parkes, J. Satsangi, 2019, BMC Gastroenterology.

Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia – a study of the Acute Leukemia Working Party of the EBMT

A. Ganser, N. Kröger, M. Labopin, 2020, Leukemia & lymphoma.

Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia

A. Ganser, M. Labopin, I. Yakoub-Agha, 2020, Blood Cancer Journal.

The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA‐matched allogeneic stem cell transplantation

J. Esteve, A. Ganser, C. Craddock, 2019, American journal of hematology.

Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT

J. Esteve, A. Ganser, M. Labopin, 2019, Haematologica.

Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis

G. Mufti, M. Labopin, A. Nagler, 2018, Journal of internal medicine.

Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)

J. Esteve, C. Craddock, M. Labopin, 2015, Leukemia.

Interest of cytogenetic and FISH evaluation for prognosis evaluation in 198 patients with acute myeloid leukemia in first complete remission in a single institution.

M. Labopin, M. Mohty, F. Delhommeau, 2014, Leukemia research.

Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia

C. Craddock, A. Zander, M. Labopin, 2011, Leukemia.

Extensive mutational status of genes and clinical outcome in pediatric acute myeloid leukemia

G. Leverger, M. Labopin, C. Preudhomme, 2010, Leukemia.

Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group

M. Labopin, C. Huber, A. Yaman, 2005, Bone Marrow Transplantation.

No impact of high‐dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission

J. Sierra, M. Labopin, D. Blaise, 2000, British journal of haematology.

Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remission

F. Baron, M. Labopin, P. Chevallier, 2019, Journal of internal medicine.

Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study.

J. Esteve, A. Ganser, G. Mufti, 2018, Blood advances.

Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study.

J. Esteve, A. Ganser, G. Mufti, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years

W. Wiktor-Jedrzejczak, M. Labopin, K. Indrák, 2009, Annals of Hematology.

Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

M. Labopin, A. Gratwohl, D. Niederwieser, 1998, Bone marrow transplantation.

Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe : further evidence of the role of marrow purging by mafosfamide

M. Labopin, R. Willemze, G. Meloni, 1991 .

Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto‐SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM‐TC

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2015, European journal of haematology.

Reduced‐intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

F. Baron, M. Labopin, A. Nagler, 2015, Cancer.

Improving results of autologous stem cell transplantation for Philadelphia-positive acute lymphoblastic leukaemia in the era of tyrosine kinase inhibitors: a report from the Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation.

H. Dombret, M. Labopin, M. Mohty, 2014, European journal of cancer.

A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study

M. Labopin, P. Chevallier, M. Mohty, 2011, Leukemia.

Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the

J. Esteve, R. Foà, M. Labopin, 2021, Leukemia.

Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC

J. Bourhis, M. Labopin, P. Chevallier, 2018, Oncotarget.

Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC

M. Perales, M. Labopin, D. Blaise, 2018, Journal of Hematology & Oncology.

Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2017, Haematologica.

TRANSPLANTATION Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation Group of Bone Transplantation

J. Esteve, J. Bourhis, F. Baron, 2015 .

Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation

F. Baron, M. Labopin, D. Blaise, 2012, Leukemia.

Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMT

M. Labopin, P. Chevallier, D. Blaise, 2012, Bone Marrow Transplantation.

Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation

M. Labopin, P. Chevallier, M. Mohty, 2011, Haematologica.

Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors?

M. Labopin, F. Ciceri, E. Gluckman, 2010, Best practice & research. Clinical haematology.

Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience.

N. Schmitz, J. Garcia-conde, M. Labopin, 1996, Bone marrow transplantation.

One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience.

M. Labopin, L. Fouillard, J. Jouet, 1994, Blood.

Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party

C. Craddock, M. Labopin, A. Nagler, 2022, Bone Marrow Transplantation.

Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission

E. Montserrat, J. Sierra, M. Labopin, 2008, Haematologica.

Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation

M. Labopin, D. Blaise, A. Nagler, 2008, Haematologica.

Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3‐ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation

J. Esteve, C. Craddock, M. Labopin, 2022, American journal of hematology.

OUTCOMES OF UCB TRANSPLANTATION ARE COMPARABLE IN FLT3+ AML: RESULTS OF CIBMTR, EUROCORD AND EBMT COLLABORATIVE ANALYSIS

F. Baron, B. Sandmaier, M. Labopin, 2016, Leukemia.

Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis

M. Labopin, D. Blaise, J. Reiffers, 2000, Bone Marrow Transplantation.

Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)

J. Esteve, A. Ganser, M. Labopin, 2022, Bone Marrow Transplantation.

Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT

J. Esteve, F. Baron, M. Labopin, 2020, Bone Marrow Transplantation.

Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire

J. Bourhis, M. Bernard, M. Labopin, 2013, European journal of haematology.

Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institution.

M. Labopin, P. Morel, P. Fenaux, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

European survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Working Party on Acute Leukemia of the European Cooperative Group for Bone Marrow Transplantation (EMBT).

A. Grañena, F. Mandelli, M. Labopin, 1994, Bone marrow transplantation.

Autologous blood stem cell transplantation versus autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. The EBMT Group Working Party for Autologous Bone Marrow Transplantation.

M. Labopin, J. Reiffers, N. Gorin, 1991, Bone marrow transplantation.

The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years—a report from the EBMT acute leukemia working party

A. Ganser, N. Kröger, C. Craddock, 2016, Journal of Hematology & Oncology.

Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party

J. Esteve, M. Labopin, P. Chevallier, 2019, Haematologica.

Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

J. Esteve, F. Baron, S. Wetten, 2019, Annals of Hematology.

Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT.

M. Labopin, A. Nagler, M. Mohty, 2018, European journal of cancer.

Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

M. Labopin, A. Nagler, M. Mohty, 2021, Transplantation and cellular therapy.

Relatively favorable outcome after allogeneic stem cell transplantation for BCR‐ABL1‐positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)

J. Esteve, M. Labopin, I. Yakoub-Agha, 2018, American journal of hematology.

Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia

J. Esteve, N. Kröger, C. Craddock, 2022, Cancer.

Growth factor‐associated graft‐versus‐host disease and mortality 10 years after allogeneic bone marrow transplantation

M. Labopin, M. Mohty, O. Ringdén, 2012, British journal of haematology.

Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT

J. Esteve, J. Bourhis, M. Labopin, 2020, Bone Marrow Transplantation.

Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia.

M. Labopin, A. Nagler, M. Mohty, 2021, Transplantation and cellular therapy.

Impact of total body irradiation‐ vs chemotherapy‐based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia

M. Labopin, D. Blaise, A. Nagler, 2020, American journal of hematology.

Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Esteve, F. Baron, M. Labopin, 2017, Haematologica.

Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation.

M. Labopin, M. Wygoda, C. Hennequin, 2007, International journal of radiation oncology, biology, physics.

Association Between The Hematopoietic Cell Transplantation-Specific Comorbidity Index (CIn) And Non-Relapse Mortality (NRM) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (Allo-SCT) For Acute Myeloid Leukemia (AML) In First Complete Remission (CR1)

N. Kröger, M. Labopin, D. Blaise, 2010 .

Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysis

A. Ganser, M. Labopin, A. Nagler, 2018, Bone Marrow Transplantation.

Posttransplant cyclophosphamide‐based anti–graft‐vs‐host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen‐mismatched unrelated donors versus haploidentical donors: A study o

M. Labopin, D. Blaise, A. Nagler, 2022, Cancer.

Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT

M. Labopin, D. Blaise, A. Nagler, 2022, Bone Marrow Transplantation.

Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party

F. Baron, M. Labopin, A. Nagler, 2020, Bone Marrow Transplantation.

Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT

L. Kanz, M. Labopin, J. Finke, 2017, Bone Marrow Transplantation.

Y. Ville, M. Labopin, A. Benachi, 2018, American journal of hematology.

Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Esteve, F. Baron, M. Labopin, 2017, Haematologica.

Clofarabine‐containing conditioning regimen for allo‐SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT

A. Ganser, M. Labopin, J. Finke, 2011, European journal of haematology.

Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia

R. Fanin, F. Baron, M. Labopin, 2022, Bone Marrow Transplantation.

Impact of Cytogenetic Risk on Outcomes of Non-T Cell Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia.

J. Esteve, R. Fanin, M. Labopin, 2022, Transplantation and cellular therapy.

Human leukocyte antigen‐haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia‐free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age

R. Fanin, F. Baron, M. Labopin, 2022 .

Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT

M. Labopin, D. Blaise, A. Nagler, 2022, Cancer medicine.

Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT

M. Labopin, I. Yakoub-Agha, D. Blaise, 2022, Bone Marrow Transplantation.

Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMT

A. Ganser, N. Kröger, F. Baron, 2021, Bone Marrow Transplantation.

Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia

N. Kröger, M. Labopin, I. Yakoub-Agha, 2020, Bone Marrow Transplantation.

Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT

H. Einsele, A. Ganser, N. Kröger, 2018, Haematologica.

Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group

A. Baruchel, G. Leverger, M. Labopin, 2018, HemaSphere.

Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

M. Labopin, D. Blaise, A. Nagler, 2015, Leukemia research.

Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT

M. Labopin, A. Nagler, M. Mohty, 2022, Bone Marrow Transplantation.

Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

M. Labopin, I. Yakoub-Agha, A. Nagler, 2021, HemaSphere.

Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2020, Annals of Hematology.

Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study

J. Sierra, M. Labopin, A. Nagler, 2019, Leukemia.

Comparable Long-Term Outcome after Allogeneic Stem-Cell Transplantation from Sibling and Matched Unrelated Donors in AML Patients Older than 50 years. A Report on Behalf of the ALWP of EBMT.

A. Ganser, M. Labopin, D. Blaise, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sequential chemotherapy followed by reduced‐intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT

A. Ganser, L. Kanz, M. Labopin, 2017, British journal of haematology.

Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party

M. Labopin, I. Yakoub-Agha, D. Blaise, 2017, Journal of Hematology & Oncology.

Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

M. Labopin, I. Yakoub-Agha, A. Nagler, 2017, Haematologica.

In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?

C. Craddock, M. Labopin, P. Chevallier, 2015, Bone Marrow Transplantation.

Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT

M. Labopin, D. Blaise, M. Mohty, 2014, Bone Marrow Transplantation.

Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2014, Bone Marrow Transplantation.

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation.

M. Labopin, D. Farge, A. Vora, 2013, Blood.

The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT

G. Mufti, C. Craddock, M. Labopin, 2013, Bone Marrow Transplantation.

Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis.

J. Esteve, J. Sierra, M. Labopin, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Disease Working Party autoimmune disease: a retrospective study of the EBMT Autoimmune Secondary autoimmune diseases occurring after HSCT for an

M. Labopin, J. Snowden, P. Veys, 2012 .

Party disease: a retrospective study of the EBMT Autoimmune Disease Working Secondary autoimmune diseases occurring after HSCT for an autoimmune

M. Labopin, J. Snowden, P. Veys, 2011 .

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire

J. Bourhis, M. Labopin, I. Yakoub-Agha, 2010, Leukemia.

remission at transplantation in adults with high-risk acute leukemia : a risk factor analysis of A survey of fully haploidentical hematopoietic stem cell transplantation

P. Bartolomeo, M. Labopin, A. Nagler, 2008 .

Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT

J. Esteve, F. Baron, M. Labopin, 2019, Haematologica.

Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT

F. Baron, M. Labopin, P. Chevallier, 2017, Journal of Hematology & Oncology.

Tracking in vivo dynamics of NK cells transferred in patients undergoing stem cell transplantation

N. Blüthgen, C. Loddenkemper, M. Labopin, 2014, European journal of immunology.

Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).

M. Labopin, G. Meloni, J. Reiffers, 1996, Bone marrow transplantation.

ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT

J. Esteve, C. Craddock, F. Baron, 2017, American journal of hematology.

Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC

M. Labopin, M. Robin, P. Chevallier, 2022, Bone Marrow Transplantation.

Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation

M. Labopin, M. Mohty, O. Legrand, 2022, Bone Marrow Transplantation.

Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic Leukemia.

H. Einsele, R. Fanin, N. Kröger, 2021, Clinical lymphoma, myeloma & leukemia.

Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation—a retrospective study by the Acute Leukemia Working Party of EBMT

M. Labopin, A. Nagler, M. Mohty, 2020, Bone Marrow Transplantation.

Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT

N. Kröger, M. Labopin, P. Chevallier, 2019, Leukemia.

Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT

M. Labopin, D. Blaise, A. Nagler, 2019, Journal of Hematology & Oncology.

Thiotepa‐based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia—A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

M. Labopin, A. Nagler, M. Mohty, 2017, American journal of hematology.

The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT).

M. Labopin, A. Gratwohl, J. Hermans, 1996, Leukemia & lymphoma.

Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease

M. Labopin, M. Aljurf, F. Locatelli, 2019, Haematologica.

Thiotepa‐based versus total body irradiation‐based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantati

M. Labopin, A. Nagler, M. Mohty, 2016, European journal of haematology.

Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT

J. Esteve, A. Ganser, F. Baron, 2016, Haematologica.

A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study

M. Labopin, D. Blaise, M. Mohty, 2021, Bone Marrow Transplantation.

Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study

M. Labopin, G. Martinelli, M. Bonafè, 2018, Bone Marrow Transplantation.

Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?

A. Fischer, A. Schulz, W. Friedrich, 2012, Blood.

Short title: Outcome of related and unrelated HSCT for SCID

A. Fischer, A. Schulz, W. Friedrich, 2017 .

A. Fischer, A. Schulz, W. Friedrich, 2014 .

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia

F. Baron, M. Labopin, P. Chevallier, 2021, Journal of Hematology & Oncology.

Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party

M. Labopin, A. Nagler, M. Mohty, 2020, Bone Marrow Transplantation.

Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial

M. Labopin, P. Ljungman, C. Cordonnier, 2015, Bone Marrow Transplantation.

Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial.

H. Einsele, M. Labopin, D. Niederwieser, 2010, Vaccine.

Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia

N. Kröger, M. Labopin, A. Nagler, 2020, Clinical Cancer Research.

Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: a retrospective analysis of the European Bone Marrow Transplant Group.

F. Mandelli, M. Labopin, A. Gratwohl, 1995, Blood.

Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation

M. Labopin, P. Ljungman, M. Remberger, 2007, Bone Marrow Transplantation.

Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis

M. Labopin, O. Ringdén, L. Fouillard, 1997, Bone Marrow Transplantation.

Characterization of late and early hematopoietic progenitor/stem cell sensitivity to mafosfamide.

M. Labopin, N. Gorin, L. Douay, 1995, Bone Marrow Transplantation.

Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).

F. Mandelli, G. Gahrton, M. Labopin, 1994, Leukemia.

The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study

M. Labopin, A. Nagler, M. Mohty, 2020, Bone Marrow Transplantation.

Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis.

M. Labopin, A. Nagler, M. Mohty, 2015, The Lancet. Haematology.

Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT

M. Labopin, D. Blaise, A. Nagler, 2022, Bone Marrow Transplantation.

Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow

M. Labopin, O. Ringdén, G. Ehninger, 2003, Bone Marrow Transplantation.

Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cells

M. Labopin, G. Meloni, M. Sanz, 2000, British journal of haematology.

Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT

N. Kröger, M. Labopin, A. Nagler, 2021, Journal of Hematology & Oncology.

Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT

M. Labopin, D. Blaise, A. Nagler, 2020, Journal of Hematology & Oncology.

Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study

M. Labopin, P. Veys, J. Wachowiak, 2020, Bone Marrow Transplantation.

Comparison of Outcomes After Allogeneic HSCT for Adult Patients with AML in Remission Using in the Conditioning Regimen Either I.V. Busulfex (BU) Plus Cyclophosphamide (Cy) or TBI Plus Cy: An- ALWP-EBMT Survey.

M. Labopin, A. Nagler, L. Volin, 2009 .

Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group–an observational analysis by the Acute Leukemia Working Party of the EBMT

C. Craddock, M. Labopin, P. Chevallier, 2015, Bone Marrow Transplantation.

Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation Transplantation and Cellular Therapy

J. Esteve, J. Bourhis, M. Labopin, 2022 .

Graft-Versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation.

J. Esteve, J. Bourhis, M. Labopin, 2021, Transplantation and cellular therapy.

Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Esteve, H. Döhner, F. Baron, 2020, Haematologica.

The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation

J. Esteve, J. Bourhis, M. Labopin, 2019, Leukemia.

Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

G. Mufti, M. Labopin, D. Blaise, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies

A. Baruchel, M. Labopin, M. Robin, 2007, Bone Marrow Transplantation.

P. Wernet, M. Labopin, E. Gluckman, 2006, Haematologica.

Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation

J. Esteve, F. Baron, M. Labopin, 2020, Bone Marrow Transplantation.

Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study.

A. Vekhoff, M. Labopin, M. Mohty, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT

R. Fanin, M. Labopin, D. Blaise, 2017, Bone Marrow Transplantation.

Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting

M. Labopin, M. Mohty, C. Hennequin, 2019, Bone Marrow Transplantation.

CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT.

A. Ganser, N. Kröger, M. Labopin, 2013, Blood.

Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT

M. Labopin, I. Yakoub-Agha, M. Mohty, 2014, Leukemia.

Graft‐versus‐host disease and graft‐versus‐leukaemia effects in secondary acute myeloid leukaemia: a retrospective, multicentre registry analysis from the Acute Leukaemia Working Party of the EBMT

N. Kröger, F. Baron, M. Labopin, 2019, British journal of haematology.

Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: A survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

J. Esteve, M. Labopin, A. Nagler, 2014, Cancer.

COVID-19 outcomes in patients with hematologic disease

M. Labopin, M. Mohty, O. Legrand, 2020, Bone Marrow Transplantation.

Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia

M. Labopin, D. Blaise, A. Nagler, 2020, Leukemia.

Dose-effect relationship for cataract induction after single-dose total body irradiation and bone marrow transplantation for acute leukemia.

M. Labopin, H. Kal, F. Frassoni, 2002, International journal of radiation oncology, biology, physics.

Impact of cord blood banking technologies on clinical outcome: a Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord retrospective analysis

M. Labopin, J. Larghero, A. Nanni Costa, 2016, Transfusion.

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

C. Hawkey, M. Labopin, J. Snowden, 2011, Bone Marrow Transplantation.

Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation

A. Fischer, G. Dini, M. Labopin, 2007, Bone Marrow Transplantation.

Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.

N. Kröger, M. Labopin, A. Nagler, 2012, Blood.

Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.

J. Esteve, M. Labopin, A. Nagler, 2010, Blood.

Reduced‐toxicity conditioning with fludarabine, once‐daily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: Results of a multicenter prospective phase 2 trial

M. Labopin, P. Chevallier, D. Blaise, 2015, Cancer.

Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation.

M. Labopin, M. Ozsahin, A. Tichelli, 1998, International journal of radiation oncology, biology, physics.

Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated AML patients: on behalf of the ALWP/EBMT

J. Esteve, C. Craddock, M. Labopin, 2022 .

Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant Study

J. Esteve, M. Labopin, P. Chevallier, 2019, Clinical hematology international.

T‐cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3‐ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Esteve, M. Labopin, D. Blaise, 2018, American journal of hematology.

Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Esteve, C. Craddock, M. Labopin, 2017, Haematologica.

Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT 3-ITD ; a study from the Acute Leukemia Working

J. Esteve, C. Craddock, M. Labopin, 2017 .

Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.

J. Kurtzberg, M. Labopin, K. Leung, 2017, Blood.

Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial.

J. Satsangi, J. Gribben, S. Vermeire, 2015, JAMA.

Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome

F. Sigaux, J. Cayuela, A. Baruchel, 2008, Haematologica.

Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institution.

M. Labopin, F. Bauters, L. Fouillard, 1999, Experimental hematology.

Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1.

C. Craddock, M. Labopin, P. Chevallier, 2017, Blood advances.

Long‐term outcome after a treosulfan‐based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

M. Labopin, A. Nagler, M. Mohty, 2017, Cancer.

Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)

M. Sormani, J. D. de Vries-Bouwstra, B. Sharrack, 2019, Bone Marrow Transplantation.

Long-term cryopreservation of human stem cells.

M. Labopin, J. Antin, N. Gorin, 1992, Bone marrow transplantation.

Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemia

A. Baruchel, G. Leverger, E. Macintyre, 2018, Leukemia.

Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Esteve, F. Baron, M. Labopin, 2018, Bone Marrow Transplantation.

Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia

J. Sierra, M. Labopin, H. Sengeløv, 2015, Leukemia.

European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation

M. Labopin, A. Nagler, A. Tichelli, 2018, Leukemia.

Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study.

Christoph Schmid, Jordi Esteve, Roni Shouval, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation

A. Vekhoff, M. Labopin, M. Mohty, 2021, JACC. CardioOncology.

Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation

J. Bourhis, M. Labopin, D. Blaise, 2019, Cancer.

Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies

A. Vekhoff, M. Labopin, M. Mohty, 2019, Bone Marrow Transplantation.

Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT

R. Fanin, M. Labopin, A. Nagler, 2019, Bone Marrow Transplantation.

Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen

F. Baron, M. Labopin, D. Blaise, 2018, Clinical Cancer Research.

Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT

M. Labopin, A. Nagler, M. Mohty, 2016, Journal of Hematology & Oncology.

Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis

F. Locatelli, M. Labopin, I. Yakoub-Agha, 2014, Bone Marrow Transplantation.

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia

M. Labopin, M. Mohty, R. Willemze, 2009, Leukemia.

Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

M. Labopin, O. Ringdén, K. Le Blanc, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT

A. Ganser, M. Labopin, I. Yakoub-Agha, 2021, Blood Cancer Journal.

Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study.

G. Dini, M. Labopin, J. Wachowiak, 2012, Blood.

Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow.

M. Labopin, J. Reiffers, O. Ringdén, 2003, Blood.

Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft

T. Barbui, M. Labopin, G. Meloni, 1999, Bone Marrow Transplantation.

Prophylactic heparin does not prevent liver veno‐occlusive disease following autologous bone marrow transplantation

M. Labopin, L. Fouillard, A. Najman, 1991, European journal of haematology.

Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia

N. Kröger, M. Labopin, D. Blaise, 2020, Leukemia.

Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission

J. Esteve, C. Craddock, M. Labopin, 2018, American journal of hematology.

The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis.

M. Labopin, D. Blaise, A. Nagler, 2017, Blood advances.

A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia

M. Labopin, A. Nagler, M. Mohty, 2014, Leukemia.

European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching

M. Labopin, A. Nagler, J. Reiffers, 1997, Bone Marrow Transplantation.

Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial

M. Labopin, P. Chevallier, D. Blaise, 2014, Haematologica.

Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation

A. Vekhoff, M. Labopin, M. Mohty, 2015, Bone Marrow Transplantation.

A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation.

Arnon Nagler, Myriam Labopin, Francesco Frassoni, 2008, Blood.

Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.

M. Labopin, A. Nagler, E. Holler, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

H. Einsele, N. Kröger, M. Labopin, 2019, Journal of Hematology & Oncology.

Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT

H. Einsele, N. Kröger, M. Labopin, 2018, Journal of Hematology & Oncology.

Impact of the addition of antithymocyte globulin to post-transplant cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplant cyclophosphamide alone in acute myeloid leukemia: a retrospective study on behalf of the Acute Leukemia Working Party of the EBMT.

M. Labopin, P. Chevallier, D. Blaise, 2022, Transplantation and cellular therapy.

Post‐transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA‐identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow T

M. Labopin, P. Chevallier, D. Blaise, 2020, Cancer.

Post-Transplant Cyclophosphamide versus Antithymocyte Globulin in HLA-Mismatched unrelated Donors transplantation.

A. Ganser, N. Kröger, M. Labopin, 2019, Blood.

RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT

J. Esteve, J. Sierra, F. Baron, 2016, Oncotarget.

Risk Factors for Outcome after Haploidentical Hematopoietic Stem Cell Transplant in Children with Very High Risk Acute Lymphoblastic Leukemia: Impact of Centre Experience. A Survey on Behalf of the ALWP and PDWP of the EBMT.

G. Dini, M. Labopin, T. Klingebiel, 2006 .

Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine

J. Sierra, F. Baron, M. Labopin, 2018, Journal of Hematology & Oncology.

Impact of ABO incompatibility on patients’ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT

M. Labopin, D. Blaise, A. Nagler, 2017, Haematologica.

Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey.

M. Labopin, J. Reiffers, O. Ringdén, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignancies

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2015, Bone Marrow Transplantation.

Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen

M. Sormani, M. Labopin, F. Locatelli, 2014, Haematologica.

Mobilized peripheral blood stem cells compared with bone marrow from HLA‐identical siblings for reduced‐intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMT

J. Gribben, G. Mufti, M. Labopin, 2012, European journal of haematology.

Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission

M. Labopin, A. Nagler, M. Mohty, 2016, Bone Marrow Transplantation.

Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?

N. Schmitz, F. Mandelli, M. Labopin, 2000 .

M. Labopin, M. Mohty, E. Deconinck, 2010 .

Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study.

M. Gobbi, M. Labopin, A. Ibatici, 2008, The Lancet. Oncology.

Measurable residual disease, FLT3‐ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1‐mutated acute myeloid leukemia

N. Kröger, M. Labopin, D. Blaise, 2022, Cancer medicine.

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP)

J. Esteve, M. Labopin, J. Finke, 2005, Leukemia.

Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.

S. Montoto, N. Kröger, M. Labopin, 2019, The Lancet. Haematology.

Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation

M. Labopin, D. Blaise, A. Nagler, 2018, American journal of hematology.

Outcome of T‐cell–replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

P. Chiusolo, M. Labopin, A. Nagler, 2021, Cancer.

Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide

M. Labopin, D. Blaise, A. Nagler, 2018, Cancer.

Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation.

M. Labopin, A. Bosi, F. Locatelli, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second A llogeneic B one M arrow T ransplantation i n A cute Leukemia: R esults o f a S urvey b y t he E uropean Cooperative G roup f or B lood a nd M arrow T ransplantation

J. Sierra, M. Labopin, A. Bosi, 2001 .

Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT

F. Baron, M. Labopin, P. Chevallier, 2019, Bone Marrow Transplantation.

Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database

M. Labopin, I. Yakoub-Agha, A. Nagler, 2016, Haematologica.

Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT

P. Chiusolo, M. Labopin, D. Blaise, 2021, Bone Marrow Transplantation.

Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2018, Bone Marrow Transplantation.

Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT

J. Esteve, A. Ganser, N. Kröger, 2017, Journal of Hematology & Oncology.

Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France

M. Labopin, I. Yakoub-Agha, D. Blaise, 2014, Haematologica.

Occurrence of graft‐versus‐host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT

F. Baron, M. Labopin, P. Chevallier, 2018, Journal of internal medicine.

Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Mal

J. Bourhis, C. Craddock, M. Labopin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Double Cord Blood Transplantation: Incidence, Organ Involvement and Risk Factors of Acute Graft Versus Host Disease. a Retrospective Analysis on Behalf of Eurocord, ALWP and Cqwp-EBMT

J. Bourhis, C. Craddock, M. Labopin, 2014 .

An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia

Peter Bader, Roni Shouval, Arnon Nagler, 2017, Clinical Cancer Research.

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia

M. Labopin, M. Mohty, R. Willemze, 2009, Leukemia.

Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Bourhis, M. Labopin, A. Nagler, 2021, Journal of Hematology & Oncology.

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

M. Caligiuri, C. Lengerke, B. Becher, 2018, Nature Medicine.

Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors

M. Labopin, D. Blaise, A. Nagler, 2020, Journal of Hematology & Oncology.

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT

A. Ganser, C. Craddock, M. Labopin, 2020, Bone Marrow Transplantation.

M. Labopin, M. Mohty, E. Deconinck, 2013, Transplantation.

Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin

N. Kröger, F. Baron, M. Labopin, 2019, Haematologica.

Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia.

M. Labopin, O. Ringdén, F. Frassoni, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant

M. Labopin, D. Blaise, A. Nagler, 2017, Haematologica.

Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties

A. Gennery, M. Labopin, J. Snowden, 2019, Front. Immunol..

Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation

J. Bourhis, G. Mufti, F. Baron, 2018, Bone Marrow Transplantation.

Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI.

J. Bourhis, M. Labopin, A. Nagler, 2019, Blood advances.

Anti‐thymocyte globulin improves survival free from relapse and graft‐versus‐host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia‐negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMT

M. Labopin, D. Blaise, A. Nagler, 2018, Cancer.

Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survival.

M. Labopin, P. Chevallier, M. Mohty, 2016, Blood.

Higher Doses of Antithymocyte Globulin (ATG) Increase the Risk of Relapse in Acute Myeloid Leukemia (AML) Patients Undergoing Matched Related Donor Allogeneic Transplantation in First Complete Remission (CR1): An Analysis from the Acute Leukemia Working Party of EBMT

J. Bourhis, F. Baron, M. Labopin, 2014 .

Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT

M. Labopin, D. Blaise, A. Nagler, 2014, Bone Marrow Transplantation.

Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation.

A. Ganser, M. Labopin, A. Nagler, 2020, Blood advances.

Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide

M. Labopin, D. Blaise, A. Nagler, 2018, Leukemia.

Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study

M. Labopin, D. Blaise, A. Nagler, 2018, American journal of hematology.

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT

M. Labopin, A. Nagler, M. Mohty, 2017, Journal of Hematology & Oncology.

Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia

J. Esteve, F. Baron, M. Labopin, 2021, Bone Marrow Transplantation.

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia – a matched pair analysis by the Acute Leukaemia Working Party of EBMT

J. Esteve, F. Baron, M. Labopin, 2018, British journal of haematology.

Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

J. Esteve, M. Labopin, I. Yakoub-Agha, 2015, Journal of Hematology & Oncology.

Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years

J. Esteve, M. Labopin, D. Blaise, 2020, Clinical Cancer Research.

Pre-emptive rituximab treatment for Epstein–Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes

M. Labopin, M. Mohty, F. Giannotti, 2019, Bone Marrow Transplantation.

Prognostic Scoring Systems in Allogeneic Hematopoietic Stem Cell Transplantation: Where Do We Stand?

M. Labopin, A. Nagler, R. Shouval, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes

J. Gribben, L. Kanz, M. Labopin, 2016, Bone Marrow Transplantation.

Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ⩾10 years

M. Labopin, P. Chevallier, A. Nagler, 2015, Bone Marrow Transplantation.

Thiotepa‐based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched‐pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

M. Labopin, J. Finke, A. Nagler, 2017, American journal of hematology.

Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT).

A. Baruchel, G. Leverger, G. Dini, 2005, Blood.

More chronic GvHD and non-relapse mortality after peripheral blood stem cell compared with bone marrow in hematopoietic transplantation for paediatric acute lymphoblastic leukemia: a retrospective study on behalf of the EBMT Paediatric Diseases Working Party

M. Labopin, P. Bader, C. Peters, 2017, Bone Marrow Transplantation.

Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia

J. Sierra, M. Labopin, J. Mary, 2000, The Lancet.

Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT.

C. Craddock, M. Labopin, A. Nagler, 2016, The oncologist.

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia

C. Craddock, M. Labopin, A. Nagler, 2017, Journal of Hematology & Oncology.

Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases.

M. Labopin, J. Snowden, D. Farge, 2017, Blood advances.

Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.

G. Lucchini, M. Labopin, P. Veys, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT

J. Esteve, M. Labopin, J. Finke, 2016, Bone Marrow Transplantation.

A. Ganser, N. Kröger, M. Labopin, 2016, Journal of Hematology & Oncology.

Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT

C. Craddock, M. Labopin, P. Chevallier, 2016, Journal of Hematology & Oncology.

Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated Donors.

M. Labopin, G. Marit, S. Dimicoli-Salazar, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Hierarchy of Alternative Donors for Allogeneic Hematopoietic Stem Cell Transplantation in Poor Risk AML in CR1: 10/10 Matched Unrelated Donors Still to be Preferred over Haplo-Identical Donors or Umbilical Cord Blood

C. Craddock, M. Labopin, P. Chevallier, 2014 .

A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality

M. Labopin, M. Mohty, G. Socié, 2014, Bone Marrow Transplantation.

AlloHSCT for inv(3)(q21;q26)/t(3;3)(q21;q26) AML: a report from the acute leukemia working party of the European society for blood and marrow transplantation

J. Esteve, N. Kröger, M. Labopin, 2018, Bone Marrow Transplantation.

Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP–EBMT analysis

M. Labopin, M. Mohty, F. Locatelli, 2012, Leukemia.

Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT

M. Labopin, I. Yakoub-Agha, D. Blaise, 2022, Bone Marrow Transplantation.

Stem Cell TransplantationDecision Making and Problem Solving

P. Wernet, M. Labopin, E. Gluckman, 2006 .

Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

M. Labopin, A. Nagler, M. Mohty, 2018, JAMA oncology.

Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2019, Bone Marrow Transplantation.

Reassessing autotransplantation for acute myeloid leukaemia in first remission – a matched pair analysis of autologous marrow vs peripheral blood stem cells

S. Singhal, J. Mehta, M. Labopin, 2004, Bone Marrow Transplantation.

Longitudinal outcome over two decades of unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: an ALWP/EBMT analysis.

H. Einsele, A. Ganser, N. Kröger, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT

J. Esteve, N. Kröger, C. Craddock, 2016, Haematologica.

Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome

N. Kröger, M. Labopin, I. Yakoub-Agha, 2014, Bone Marrow Transplantation.

Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT

M. Labopin, A. Nagler, M. Mohty, 2018, American journal of hematology/oncology.

Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT

J. Esteve, M. Labopin, A. Nagler, 2016, Haematologica.

The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Arnon Nagler, Myriam Labopin, M. Labopin, 2015, Haematologica.

Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

J. Esteve, M. Labopin, A. Nagler, 2015, The oncologist.

Total-body irradiation before bone-marrow transplantation for acute leukemia in first or second complete remission

E. Touboul, M. Labopin, M. Schlienger, 1994 .

Fludarabine, IV Busulfan and Antithymocyte Globulins-Based Reduced-Toxicity Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation (allo-SCT): Results of a Multicenter Prospective Trial

M. Labopin, P. Chevallier, D. Blaise, 2012 .

Increase of Suicide and Accidental Death After Hematopoietic Stem Cell Transplantation

M. Labopin, J. Passweg, A. Tichelli, 2013, Cancer.

Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registry

M. Labopin, A. Gratwohl, L. Fouillard, 2002, Bone Marrow Transplantation.

T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis

M. Labopin, A. Nagler, M. Mohty, 2015, Haematologica.

Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

R. Berger, M. Labopin, A. Nagler, 2014, Haematologica.

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation.

J. Esteve, J. Bourhis, F. Baron, 2015, Blood.

Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry.

S. Montoto, F. Baron, M. Perales, 2021, The Lancet. Haematology.

Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT

W. Wiktor-Jedrzejczak, N. Kröger, M. Labopin, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMT.

M. Labopin, P. Chevallier, D. Blaise, 2019, European journal of cancer.

Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia

J. Esteve, N. Kröger, C. Craddock, 2015, Haematologica.

Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects

M. Labopin, A. Nagler, M. Mohty, 2015, Bone Marrow Transplantation.

Second allogeneic haematopoietic cell transplantation using HLA‐matched unrelated versus T‐cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia

A. Ganser, M. Labopin, P. Chevallier, 2021, British journal of haematology.

Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT

N. Kröger, M. Labopin, P. Chevallier, 2019, Blood Cancer Journal.

Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT

R. Fanin, M. Labopin, A. Nagler, 2016, Cancer.

Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation

F. Lo‐Coco, M. Labopin, G. Meloni, 2007, Bone Marrow Transplantation.

Physicians Abstracts

J. Esteve, R. Unger, R. Unger, 2015, Bone Marrow Transplantation.

Isocitrate Dehydrogenase (IDH) 1 and 2 Mutation Is an Independent Predictor of Better Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Study of the ALWP of EBMT

J. Esteve, A. Ganser, J. Bourhis, 2021, Blood.

Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission

J. Esteve, M. Labopin, P. Chevallier, 2018, American journal of hematology.

Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantation

M. Labopin, D. Blaise, J. Reiffers, 2003, Leukemia.

Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

M. Labopin, I. Yakoub-Agha, D. Blaise, 2019, Clinical rheumatology.

Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients

M. Labopin, A. Tichelli, G. Basak, 2019, JAMA oncology.

Impact of Cytogenetics Risk on Outcome after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) from An HLA Identical Sibling for Patients with Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)

M. Labopin, D. Blaise, M. Mohty, 2008 .

The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed

M. Labopin, D. Blaise, G. Meloni, 2000, Bone Marrow Transplantation.

GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT

R. Fanin, P. Chiusolo, F. Baron, 2023, Journal of Hematology & Oncology.

HLA-haploidentical transplantation for relapsed/refractory AML: better LFS with BM than with PBSC in patients ≥ 55 years of age.

R. Fanin, F. Baron, M. Labopin, 2022, American journal of hematology.

The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML

M. Labopin, D. Blaise, A. Nagler, 2022, Bone Marrow Transplantation.

The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT)

J. Esteve, A. Ganser, M. Labopin, 2020, American journal of hematology.

Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study

J. Bourhis, M. Labopin, I. Yakoub-Agha, 2022, Bone Marrow Transplantation.

Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT

M. Labopin, J. Finke, A. Nagler, 2017, Oncotarget.

Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission

J. Esteve, M. Labopin, D. Blaise, 2020, Bone Marrow Transplantation.

F. Baron, M. Labopin, A. Nagler, 2019, Bone Marrow Transplantation.

Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status

J. Esteve, J. Bourhis, M. Labopin, 2016, Haematologica.

Incident hyperglycemia, parenteral nutrition administration and adverse outcomes in patients with myeloma admitted for initial autologous stem cell transplant

C. Braunschweig, G. Leone, M. Labopin, 2013, Bone Marrow Transplantation.

Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

N. Kröger, M. Labopin, I. Yakoub-Agha, 2021, Bone Marrow Transplantation.

Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT)

J. Esteve, N. Kröger, M. Labopin, 2020, Cancer medicine.

Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation.

G. Mufti, M. Labopin, P. Chevallier, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of detectable measurable residual disease on umbilical cord blood transplantation

J. Sierra, F. Baron, M. Labopin, 2020, American journal of hematology.

Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia

J. Esteve, J. Bourhis, M. Labopin, 2019, Leukemia.

Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT

J. Bourhis, M. Labopin, A. Nagler, 2023, Bone Marrow Transplantation.

Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Bourhis, M. Labopin, I. Yakoub-Agha, 2023, Bone Marrow Transplantation.

Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT

A. Ganser, J. Bourhis, M. Labopin, 2023, HemaSphere.

Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia

N. Kröger, M. Labopin, I. Yakoub-Agha, 2022, Bone Marrow Transplantation.

Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study

A. Ganser, M. Labopin, P. Chevallier, 2019, Bone Marrow Transplantation.

Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Esteve, J. Bourhis, G. Mufti, 2019, Haematologica.

Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post‐transplant cyclophosphamide in AML in first complete remission

M. Labopin, I. Yakoub-Agha, D. Blaise, 2023, British journal of haematology.

Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT

J. Esteve, N. Kröger, M. Labopin, 2021, Bone Marrow Transplantation.

Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center

J. Esteve, M. Labopin, P. Chevallier, 2018, Cancer.

Individualized prediction of leukemia‐free survival after autologous stem cell transplantation in acute myeloid leukemia

M. Labopin, D. Blaise, A. Nagler, 2019, Cancer.

Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: a report from the EBMT acute leukemia working party.

M. Labopin, D. Blaise, A. Nagler, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia

M. Labopin, I. Yakoub-Agha, A. Nagler, 2018, American journal of hematology.

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission

G. Mufti, M. Labopin, P. Chevallier, 2017, Oncotarget.

Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph‐negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation

M. Labopin, I. Yakoub-Agha, A. Nagler, 2018, American journal of hematology.

Validation of the acute leukemia‐EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi‐center GITMO cohort

R. Unger, M. Labopin, A. Nagler, 2017, American journal of hematology.

Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study

Christoph Schmid, Jordi Esteve, Roni Shouval, 2016, PloS one.

Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)

M. Labopin, M. Mohty, J. Snowden, 2023, Bone Marrow Transplantation.

Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis

M. Labopin, P. Chevallier, D. Blaise, 2023, HemaSphere.

Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen

M. Labopin, D. Blaise, A. Nagler, 2012 .

Timing of Post-Transplantation Cyclophosphamide Administration in Haploidentical Transplantation: A Comparative Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

P. Chiusolo, M. Labopin, A. Nagler, 2020 .

Tolerability and Efficacy of Treatment With Azacytidine as Prophylactic or Preemptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation.

A. Vekhoff, M. Labopin, M. Mohty, 2019, Clinical lymphoma, myeloma & leukemia.

Investigating covariate-by-centre interaction in survival data

S. Chevret, M. Labopin, L. Biard, 2018, Statistical methods in medical research.

Post-Transplant Cyclophosphamide (PT-Cy) for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Transplantation from HLA Identical Sibling and Matched Unrelated Donor for Patients with Acute Leukemia, on Behalf of ALWP-EBMT

N. Kröger, M. Labopin, D. Blaise, 2017 .

Use of Bone Marrow or Peripheral Blood Stem Cell Grafts in Non T Cell Depleted Haploidentical Transplants Using Post-Transplant Cyclophosphamide, an ALWP-EBMT Analysis

M. Labopin, D. Blaise, A. Nagler, 2016 .

Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT

J. Esteve, M. Labopin, A. Nagler, 2017, Haematologica.

Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission

C. Craddock, M. Labopin, A. Nagler, 2020, Bone Marrow Transplantation.

Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study

N. Kröger, M. Labopin, A. Nagler, 2021, Bone Marrow Transplantation.

Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party

N. Kröger, M. Labopin, A. Nagler, 2019, Bone Marrow Transplantation.

Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission.

J. Troy, J. Kurtzberg, M. Labopin, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).

M. Labopin, A. Gratwohl, J. Reiffers, 1997, Leukemia.

Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years

M. Labopin, R. Willemze, A. Gratwohl, 1997, Leukemia.

CNS Involvement at Initial Diagnosis and Risk of Relapse After Allogeneic HCT for Acute Lymphoblastic Leukemia in First Complete Remission

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2022, HemaSphere.

Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party

H. Tilly, M. Labopin, A. Nagler, 2020, Bone Marrow Transplantation.

Autologous Haematopoietic Stem Cell Transplantation for Crohn’s Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation

J. Satsangi, S. Vermeire, C. Hawkey, 2018, Journal of Crohn's & colitis.

OP021 Autologous haematopoietic stem cell transplantation for Crohn’s disease: a retrospective study from the European Society for Blood & Marrow Transplantation (EBMT) Autoimmune Diseases Working Party

J. Satsangi, S. Vermeire, C. Hawkey, 2018 .

T‐cell–depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT)

L. Kanz, M. Labopin, A. Nagler, 2018, Cancer.

Interpretable Boosted Decision Trees for Prediction of Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation

Roni Shouval, Arnon Nagler, Myriam Labopin, 2016 .

analysis of the European Bone Marrow Transplant Group retrospective myeloblastic leukemia in patients older than 50 years: a Autologous bone marrow transplantation for first remission acute

F. Mandelli, M. Labopin, A. Gratwohl, 2011 .

Title: Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia

M. Labopin, A. Nagler, M. Mohty, 2018 .

Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT

A. Ganser, C. Craddock, M. Labopin, 2022, Bone Marrow Transplantation.

Comparative outcomes of myeloablative and reduced‐intensity conditioning allogeneic hematopoietic cell transplantation for therapy‐related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation

A. Ganser, J. Bourhis, M. Labopin, 2019, American journal of hematology/oncology.

Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

T. Barbui, M. Labopin, G. Meloni, 1999, Bone marrow transplantation.

Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITD.

M. Labopin, G. Marit, F. Mahon, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Post‐transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA‐mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT

R. Fanin, M. Labopin, I. Yakoub-Agha, 2022, American journal of hematology.

M. Labopin, D. Blaise, A. Nagler, 2022, Bone Marrow Transplantation.

High‐dose post‐transplant cyclophosphamide impairs γδ T‐cell reconstitution after haploidentical haematopoietic stem cell transplantation using low‐dose antithymocyte globulin and peripheral blood stem cell graft

M. Labopin, M. Mohty, B. Gaugler, 2020, Clinical & translational immunology.

Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study

M. Labopin, D. Blaise, M. Mohty, 2016, Haematologica.

Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over

M. Labopin, D. Blaise, A. Nagler, 2019, Cancer.

Shannon R. McCurdy, J. Bourhis, M. Labopin, 2018, Blood advances.

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia

P. Vyas, J. Bourhis, C. Craddock, 2018, Journal of internal medicine.

Outcomes After Double Unit Unrelated Cord Blood Transplantation (UCBT) Compared with Single UCBT In Adults with Acute Leukemia In Remission. An Eurocord and ALWP Collaboration Study

M. Labopin, I. Yakoub-Agha, M. Mohty, 2010 .

Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia.

A. Ganser, M. Labopin, D. Blaise, 2010, Blood.

Gemtuzumab Ozogamicin Combined With Intensive Chemotherapy in Patients With Acute Myeloid Leukemia Relapsing After Allogenic Stem Cell Transplantation.

M. Labopin, M. Mohty, O. Legrand, 2020, Clinical lymphoma, myeloma & leukemia.

Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.

M. Labopin, G. Meloni, L. Fouillard, 2004, Haematologica.

Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT

M. Labopin, D. Blaise, A. Nagler, 2021, Bone Marrow Transplantation.

The Role of Donor Selection for a Second Allogeneic Stem Cell Transplantation in Patients with AML Relapsing after a First Transplant; A Study on Behalf of the Acute Leukemia Working Party of EBMT

N. Kröger, M. Labopin, P. Chevallier, 2018, Biology of Blood and Marrow Transplantation.

Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trial

M. Labopin, M. Mohty, P. Rohrlich, 2022, Bone Marrow Transplantation.

Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party

G. Comi, F. Piehl, M. Labopin, 2015, Multiple sclerosis.

Working Parties

M. Labopin, P. Chevallier, A. Nagler, 2015, Bone Marrow Transplantation.

Hematopoietic cell transplant nurse coordinators’ perceptions of related donor care: a European survey from the EBMT Nurses Group

M. Labopin, M. Badoglio, S. Liptrott, 2019, Bone Marrow Transplantation.

Outcomes of Unrelated Cord Blood and Haploidentical Stem Cell Transplantation in Adults with Acute Leukaemia.

P. Bartolomeo, M. Labopin, M. Martelli, 2005 .

Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMT

M. Labopin, I. Yakoub-Agha, A. Nagler, 2022, Bone Marrow Transplantation.

Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remission

R. Schlenk, M. Labopin, D. Blaise, 2014, Leukemia.

(EBMT) study of the European Group for Blood and Marrow Transplantation Hematopoietic stem cell transplantation for de novo erythroleukemia: a

M. Labopin, R. Willemze, G. Meloni, 2013 .

Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT).

M. Labopin, R. Willemze, G. Meloni, 2002, Blood.

A haploidentical may be a better choice than a female genoidentical donor to transplant a patient with high risk acute myelogenous leukemia in first remission

J. Bourhis, M. Labopin, D. Blaise, 2019 .

M. Labopin, D. Blaise, M. Mohty, 2023, Journal of Hematology & Oncology.

Acute myeloid leukemia Prognostic signi fi cance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia

J. Esteve, J. Bourhis, M. Labopin, 2019 .

Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).

M. Labopin, G. Meloni, V. Rizzoli, 1991, Leukemia.

The timing of post-transplant cyclophosphamide administration in haploidentical transplantation: a comparative study on behalf of the ALWP of the EBMT.

P. Chiusolo, M. Labopin, A. Nagler, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplant.

A. Schulz, A. Gennery, M. Labopin, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Impact of Center Experience on Results of Reduced Intensity – Allogeneic Hematopoietic Stem Cell Transplantation. A Survey From the Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow Transplantation (EBMT)

C. Craddock, M. Labopin, D. Blaise, 2010 .

20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation.

M. Labopin, I. Yakoub-Agha, D. Blaise, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Retrospective Comparison between 12-Gray and 8-Gray Total Body Irradiation (TBI) before Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia in First Complete Remission

A. Ganser, J. Bourhis, N. Kröger, 2021, Blood.

Reply to F. Ferrara et al

M. Labopin, N. Gorin, V. Rocha, 2010 .

M. Labopin, P. Chevallier, M. Mohty, 2014 .

Autologous bone marrow transplantation for childhood acute myeloid leukemia : a European survey

M. Labopin, P. Tiberghien, P. Hervé, 1991 .

Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT

M. Labopin, D. Blaise, A. Nagler, 2016, American journal of hematology.

Impact of FAB classification on predicting outcome in acute myeloid leukemia , not otherwise specified , patients undergoing allogeneic stem cell transplantation in CR 1

M. Labopin, D. Blaise, A. Nagler, 2022 .

Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK‐NUP214 shows a favourable outcome when performed in first complete remission

J. Esteve, J. Sierra, M. Labopin, 2020, British journal of haematology.

Competing risks regression for clustered data.

Myriam Labopin, Jason Fine, Bingqing Zhou, 2012, Biostatistics.

Comparison of Matched-Sibling Donors Versus Unrelated Donors in Allogeneic Stem Cell Transplantation (allo-SCT) for Primary Refractory Acute Myeloid Leukemia (PRF AML): A Report of 1041 Patients from the Acute Leukemia Working Party of the EBMT

J. Esteve, A. Ganser, M. Labopin, 2015 .

Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Autoimmune Diseases: 10 Years Experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases

M. Labopin, A. Gratwohl, J. Ouyang, 2008 .

Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia—a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

P. Galieni, M. Labopin, A. Nagler, 2023, Bone Marrow Transplantation.

M. Labopin, I. Yakoub-Agha, D. Blaise, 2022, Bone marrow transplantation.

Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT

J. Bourhis, M. Labopin, P. Chevallier, 2017, American journal of hematology.

Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation

J. Bourhis, M. Labopin, P. Chevallier, 2022 .

Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

M. Heuser, M. Labopin, I. Yakoub-Agha, 2023, Bone marrow transplantation.

Outcomes of graft failure after umbilical cord blood transplantation in acute leukemia: a study from Eurocord and the Acute Leukemia Working Party of the EBMT

J. Bourhis, F. Baron, M. Labopin, 2023, Bone Marrow Transplantation.

Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years—a registry-based study by the Acute Leukemia Working Party of the EBMT

J. Bourhis, M. Labopin, P. Chevallier, 2023, Bone Marrow Transplantation.

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with T-Cell Acute Lymphoblastic Leukemia: A Survey From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

J. Esteve, M. Labopin, I. Yakoub-Agha, 2012 .

Post remission consolidation by autologous HCT for AML in CR1, negative implications for subsequent allogeneic HCT in CR2. A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

M. Labopin, I. Yakoub-Agha, D. Blaise, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

PF747 DEFIBROTIDE TREATMENT IN ADULTS WITH SEVERE OR VERY SEVERE VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME AFTER HEMATOPOIETIC CELL TRANSPLANTATION: DEFIFRANCE STUDY INTERIM RESULTS

M. Labopin, I. Yakoub-Agha, D. Blaise, 2019, HemaSphere.

Efficacy of recombinant human erythropoietin in the treatment of refractory anemias without excess of blasts in myelodysplastic syndromes.

M. Labopin, P. Fenaux, B. Jaar, 1994, Leukemia & lymphoma.

Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia

A. Ganser, M. Labopin, I. Yakoub-Agha, 2020, Blood Cancer Journal.

Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT

M. Labopin, D. Blaise, A. Nagler, 2023, Journal of Hematology & Oncology.

Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT

M. Labopin, A. Nagler, M. Mohty, 2023, Bone Marrow Transplantation.

Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study

M. Labopin, P. Chevallier, A. Nagler, 2023, Blood Advances.

Autologous bone marrow transplantation in 2502 patients with acute leukemia in Europe: a retrospective study.

M. Labopin, N. Gorin, 1992, Leukemia.

Autologous HSCT for Ph-Positive Adult Acute Lymphoblastic Leukemia: A Curative Option in the Era of Tyrosine Kinase Inhibitors? an Analysis From the Acute Leukemia Working Party of the EBMT

M. Labopin, M. Mohty, G. Socié, 2012 .

Significance of Degree of HLA Disparity Using T-cell Replete Peripheral Blood Stem Cells From Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First Complete Hematologic Remission: A Study of the Acute Leukemia Working Party of the EBMT

R. Fanin, M. Labopin, D. Blaise, 2023, HemaSphere.

Allogeneic Hematopoietic Cell Transplantation in AML with Normal Karyotype and NPM1 Mutated FLT3-ITD Negative: A Retrospective Analysis from the Acute Leukemia Working Party of EBMT

J. Esteve, J. Bourhis, M. Labopin, 2014 .

Describing and analyzing complex disease history in retrospective studies.

M. Labopin, A. Boumendil, 2023, Best practice & research. Clinical haematology.

Sequential Regimen of Clofarabine, Cytarabine and Reduced Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in Primary Treatment Failure

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2014 .

PV-0042: Fractionated-TBI schedules prior to allograft: Study from the Acute Leukemia Working Party (EBMT)

M. Labopin, I. Yakoub-Agha, A. Nagler, 2017 .

Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP).

M. Labopin, I. Yakoub-Agha, A. Nagler, 2023, Bone marrow transplantation.

Autologous Hematopoietic Cell Transplantation in Elderly Patients Aged 65 and Older: A Retrospective Analysis By the Complications and Quality of Life Working Party of the EBMT

S. Montoto, H. Goldschmidt, H. Einsele, 2016 .

Haematopoietic stem cell transplantation in children in eastern European countries 1985–2004: development, recent activity and role of the EBMT/ESH Outreach Programme

G. Dini, M. Labopin, J. Wachowiak, 2008, Bone Marrow Transplantation.

Comparison of RIC-alloHCT and autoHCT for > 55 years old patients with acute lymphoblastic leukemia: an analysis from Acute Leukemia Working Party of the EBMT

M. Labopin, A. Nagler, M. Mohty, 2015 .

Equivalent Outcome Between Older Siblings and Unrelated Donors After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Patients Older Than 50 Years with Acute Myeloid Leukemia in First Complete Remission: A Report From the ALWP of EBMT

C. Craddock, M. Labopin, D. Blaise, 2012 .

Association Between the Hematopoietic Cell Transplantation-Specific Comorbidity Index (CI) and Non-Relapse Mortality (NRM) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).

N. Kröger, M. Labopin, D. Blaise, 2009 .

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Lymphoblastic Leukemia (ALL): A Survey from the European Group for Blood and Marrow Transplantation (EBMT).

M. Labopin, D. Blaise, M. Mohty, 2005 .

Immune Response to the 23-Valent Polysaccharide Pneumococcal Vaccine (PPV23) after the 7-Valent Conjugate Vaccine (PCV7) in Allogeneic Stem Cell Transplant (SCT) Recipients: Results of the EBMT IDWP01 Trial

H. Einsele, M. Labopin, D. Niederwieser, 2008 .

Incidence and Risk Factors of Chronic Graft-Versus-Host Disease After Unrelated Cord Blood Transplant In Children and Adults. A Retrospective Study on Behalf of EUROCORD and Late-Effect Working Party of EBMT

G. Dini, M. Labopin, D. Blaise, 2010 .

P O B O X 1 1 7 2 2 1 0 0 L U N D + 4 6 4 6 -2 2 2 0 0 0 0

J. Esteve, C. Craddock, M. Labopin, 2022 .

Comparison of Reduced Intensity Conditioning - Allogeneic HCT and Autologous HCT for Elderly Patients with Acute Lymphoblastic Leukemia. an Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Bourhis, M. Labopin, I. Yakoub-Agha, 2020 .

Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis

F. Locatelli, M. Labopin, I. Yakoub-Agha, 2014, Bone Marrow Transplantation.

Reduced Post-Transplant Cyclophosphamide Dose Associated with Antithymocyte Globulin in Peripheral Blood Stem Cell Haploidentical Transplantation

A. Cohen, M. Labopin, M. Mohty, 2022, Blood.

RIC Allo-SCT with Flu/Bu in Comparison to Flu/Mel for AML Results in Similar Overall Survival: A Report from the ALWP of the EBMT

F. Baron, M. Labopin, A. Nagler, 2014 .

Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.

J. Esteve, C. Craddock, M. Labopin, 2022 .

P O B O X 1 1 7 2 2 1 0 0 L U N D + 4 6 4 6 -2 2 2 0 0 0 0

J. Esteve, M. Labopin, I. Yakoub-Agha, 2022 .

Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukemia in patients over 60 years of age

M. Labopin, G. Meloni, M. Sanz, 2000 .

University of Birmingham Allogeneic stem cell transplantation benefits for patients 60 years with acute myeloid leukemia and FLT3 internal tandem duplication:

J. Esteve, M. Labopin, P. Chevallier, 2018 .

Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

A. Børresen-Dale, J. Esteve, C. Desmedt, 2017 .

Hematopoietic Stem Cell Transplantation from HLA Identical Sibling Forsickle Cell Disease an International Survey on Behalf of Eurocord-Monacord, EBMT Paediatric Disease Working Party and CIBMTR

M. Labopin, M. Robin, F. Locatelli, 2015 .

Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study

M. Labopin, P. Chevallier, A. Nagler, 2023, Blood advances.

Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT

J. Esteve, M. Labopin, A. Nagler, 2017, Haematologica.

Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT

M. Labopin, M. Mohty, F. Lanza, 2023, Bone Marrow Transplantation.

Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT

M. Labopin, D. Blaise, A. Nagler, 2023, Journal of Hematology & Oncology.

Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1.

C. Craddock, M. Labopin, P. Chevallier, 2017, Blood advances.

Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

S. Montoto, A. Gennery, N. Kröger, 2019, Bone Marrow Transplantation.

Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?

A. Schulz, W. Friedrich, A. Gennery, 2012, Blood.

Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis.

M. Labopin, A. Nagler, M. Mohty, 2015, The Lancet. Haematology.

Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2017, Haematologica.

Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.

N. Kröger, M. Labopin, A. Nagler, 2012, Blood.

Haploidentical stem cell transplantation abrogates the prognostic impact of FLT3-ITD in acute myeloid leukemia. A report from the Acute Leukemia Working Party of the EBMT

Blaise., J. Esteve, M. Labopin, 2022 .

Prediction of Non-Relapse Mortality in Recipients of Reduced Intensity Conditioning Allo-HSCT with Acute Myeloid Leukemia in First Complete Remission: Integrating the Seattle Comorbidity Index (HCT-CI) and EBMT Scoring Systems

R. Schlenk, M. Labopin, D. Blaise, 2012 .

Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation

A. Cohen, M. Labopin, M. Mohty, 2023, Bone Marrow Transplantation.

M. Labopin, I. Yakoub-Agha, D. Blaise, 2023, Bone Marrow Transplantation.

M. Labopin, I. Yakoub-Agha, A. Nagler, 2022, HemaSphere.

Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting

M. Labopin, M. Mohty, C. Hennequin, 2019, Bone Marrow Transplantation.

CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT.

A. Ganser, N. Kröger, M. Labopin, 2013, Blood.

A. Grañena, G. Gahrton, M. Labopin, 1996, Bone marrow transplantation.

M. Labopin, D. Blaise, M. Mohty, 2017 .

M. Labopin, D. Blaise, A. Nagler, 2015, Leukemia research.

Intravenous Busulfan-Based Conditioning Prior to Allogeneic Stem Cell Transplantation in Adults Patients with AML - An ALWP-EBMT Survey.

A. Zander, M. Labopin, A. Nagler, 2007 .

Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study

M. Labopin, P. Veys, J. Wachowiak, 2021, Bone Marrow Transplantation.

Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission.

M. Labopin, D. Blaise, G. Meloni, 2010, Blood.

Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study

M. Labopin, P. Veys, J. Wachowiak, 2017 .

Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMT

M. Labopin, D. Blaise, A. Nagler, 2023, HemaSphere.

Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT

M. Labopin, M. Mohty, M. Itälä-Remes, 2024, Blood advances.

stem cell transplantation severe

M. Labopin, E. Snarski, M. Badoglio, 2019 .

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Severe Auto-Immune Disease Adult Patients: Analysis of Outcomes from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGMT-TC) in Light of the European Society for Blood and Marrow Transplantation (EBMT) Activity

M. Labopin, I. Yakoub-Agha, D. Blaise, 2015 .

Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?

M. Labopin, J. Finke, J. Snowden, 2016, Bone Marrow Transplantation.

Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial

M. Labopin, D. Blaise, M. Mohty, 2024, Blood cancer journal.

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation.

J. Esteve, J. Bourhis, F. Baron, 2015, Blood.

Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT).

M. Labopin, M. Mohty, M. Itälä-Remes, 2024, Bone marrow transplantation.

Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission.

J. Troy, J. Kurtzberg, M. Labopin, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis

M. Labopin, A. Nagler, M. Mohty, 2015, Haematologica.

Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT.

M. Labopin, M. Mohty, U. Salmenniemi, 2024, Bone marrow transplantation.

Impact of the type of tyrosine kinase inhibitor (imatinib or dasatinib) used before allo-HCT on outcome of patients with Philadelphia-positive acute lymphoblastic leukemia. A study on behalf of the Acute Leukemia Working Party of the EBMT.

M. Labopin, M. Mohty, U. Salmenniemi, 2024, Transplantation and cellular therapy.

The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT

M. Labopin, A. Nagler, M. Mohty, 2023, Bone Marrow Transplantation.

Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.

M. Labopin, D. Blaise, M. Mohty, 2024, Cancer.

Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplanta

M. Labopin, D. Blaise, A. Nagler, 2023, Cancer.

Haploidentical transplantation in primary refractory/relapsed secondary vs de novo AML: from the ALWP/EBMT

M. Labopin, M. Mohty, E. Forcade, 2024, Blood advances.

Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT

M. Labopin, D. Blaise, M. Mohty, 2023, Journal of Hematology & Oncology.

Thiotepa-based regimens are a valid alternative to total body irradiation-based reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia: a retrospective study on behalf of the Acute Leukemia Working Party of the EBMT.

M. Labopin, M. Mohty, A. Spyridonidis, 2023, Transplantation and cellular therapy.

Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study

J. Sierra, M. Labopin, A. Nagler, 2019, Leukemia.

N. Kröger, M. Labopin, I. Yakoub-Agha, 2022, Bone Marrow Transplantation.

J. Esteve, M. Labopin, A. Nagler, 2015, The oncologist.

J. Bourhis, C. Craddock, M. Labopin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.